BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23778569)

  • 1. Validation of organ procurement and transplant network (OPTN)/united network for organ sharing (UNOS) criteria for imaging diagnosis of hepatocellular carcinoma.
    Fowler KJ; Karimova EJ; Arauz AR; Saad NE; Brunt EM; Chapman WC; Heiken JP
    Transplantation; 2013 Jun; 95(12):1506-11. PubMed ID: 23778569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New OPTN/UNOS classification system for nodules in cirrhotic livers detected with MR imaging: effect on hepatocellular carcinoma detection and transplantation allocation.
    Rosenkrantz AB; Campbell N; Wehrli N; Triolo MJ; Kim S
    Radiology; 2015 Feb; 274(2):426-33. PubMed ID: 25299785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance of hypervascular liver nodule characterization between the organ procurement and transplant network and liver imaging reporting and data system classifications.
    Bashir MR; Huang R; Mayes N; Marin D; Berg CL; Nelson RC; Jaffe TA
    J Magn Reson Imaging; 2015 Aug; 42(2):305-14. PubMed ID: 25371354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma.
    Wald C; Russo MW; Heimbach JK; Hussain HK; Pomfret EA; Bruix J
    Radiology; 2013 Feb; 266(2):376-82. PubMed ID: 23362092
    [No Abstract]   [Full Text] [Related]  

  • 5. An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma.
    Kemmer N; Neff G; Kaiser T; Zacharias V; Thomas M; Tevar A; Satwah S; Shukla R; Buell J
    Liver Transpl; 2006 Oct; 12(10):1519-22. PubMed ID: 17004260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.
    Schwartz JJ; Pappas L; Thiesset HF; Vargas G; Sorensen JB; Kim RD; Hutson WR; Boucher K; Box T
    Liver Transpl; 2012 Apr; 18(4):423-33. PubMed ID: 22250078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of liver biopsy and noninvasive methods for diagnosis of hepatocellular carcinoma.
    Bialecki ES; Ezenekwe AM; Brunt EM; Collins BT; Ponder TB; Bieneman BK; Di Bisceglie AM
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):361-8. PubMed ID: 16527701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation.
    Lao OB; Weissman J; Perkins JD
    Clin Transplant; 2009; 23(6):874-81. PubMed ID: 19453644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI.
    Choi SH; Lee JM; Yu NC; Suh KS; Jang JJ; Kim SH; Choi BI
    AJR Am J Roentgenol; 2008 Aug; 191(2):529-36. PubMed ID: 18647927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies.
    Willatt JM; Hussain HK; Adusumilli S; Marrero JA
    Radiology; 2008 May; 247(2):311-30. PubMed ID: 18430871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Mandatory 6-Month Waiting Period on Waitlist and Transplant Outcomes in Patients With Hepatocellular Carcinoma.
    Nagai S; Kitajima T; Yeddula S; Salgia R; Schilke R; Abouljoud MS; Moonka D
    Hepatology; 2020 Dec; 72(6):2051-2062. PubMed ID: 32157711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misdiagnosis of hepatocellular carcinoma in patients receiving no local-regional therapy prior to liver transplant: An analysis of the Organ Procurement and Transplantation Network explant pathology form.
    Mehta N; Dodge JL; Roberts JP; Hirose R; Yao FY
    Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28881064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An early look at the Organ Procurement and Transplantation Network explant pathology form data.
    Harper AM; Edwards E; Washburn WK; Heimbach J
    Liver Transpl; 2016 Jun; 22(6):757-64. PubMed ID: 26970341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted MRI with gadolinium-enhanced MRI using liver explantation standard.
    Hardie AD; Kizziah MK; Rissing MS
    J Comput Assist Tomogr; 2011; 35(6):711-5. PubMed ID: 22082541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation.
    Chapman WC; Majella Doyle MB; Stuart JE; Vachharajani N; Crippin JS; Anderson CD; Lowell JA; Shenoy S; Darcy MD; Brown DB
    Ann Surg; 2008 Oct; 248(4):617-25. PubMed ID: 18936575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadolinium-enhanced MRI for tumor surveillance before liver transplantation: center-based experience.
    Lauenstein TC; Salman K; Morreira R; Heffron T; Spivey JR; Martinez E; Sharma P; Martin DR
    AJR Am J Roentgenol; 2007 Sep; 189(3):663-70. PubMed ID: 17715115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
    De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
    Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Organ Procurement and Transplantation Network hepatocellular carcinoma classification: Alignment with Liver Imaging Reporting and Data System, current gaps, and future direction.
    Kierans AS; Chernyak V; Mendiratta-Lala M; Sirlin CB; Hecht EM; Fowler KJ
    Liver Transpl; 2023 Feb; 29(2):206-216. PubMed ID: 36097856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma.
    Samuel D; Colombo M; El-Serag H; Sobesky R; Heaton N
    Liver Transpl; 2011 Oct; 17 Suppl 2():S6-13. PubMed ID: 21858912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of noninvasive diagnostic criteria for hepatocellular carcinoma on pretransplant MRI (2010): correlation between MR imaging features and histological features on liver specimen].
    Ouedraogo W; Tran-Van Nhieu J; Baranes L; Lin SJ; Decaens T; Laurent A; Djabbari M; Pigneur F; Duvoux C; Kobeiter H; Deux JF; Rahmouni A; Luciani A
    J Radiol; 2011; 92(7-8):688-700. PubMed ID: 21819911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.